EMAIL THIS PAGE TO A FRIEND

Molecular Cancer Therapeutics

Gemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cells.


PMID 19139112

Abstract

We're sorry this abstract is currently not available.